| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 |
BIOSIGNAL LIMITED (BOS)
Stock Code: BOS
Listing Date: 2000-06-28 00:00:00
Website: http://www.biosignal.com.au
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Development of novel anti-bacterials
Address:
Australian Technology Park, National Innovation Centre, Level 1, Suite 145
EVELEIGH
NSW 1430
Phone: (02) 9209 4126
Fax: (02) 9209 4306
Executives & Directors
Dr John S Keniry, Chairman
Prof. Peter D Steinberg, Director, CEO
Prof. Gunter A Pauli, Non Exec. Director
Mr Bruce E Foy, Non Exec. Director
Mr Rohan J McDougall, Chief Op. Officer
Mr Robert C Vickery, CFO
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
Excellence in Biotechnology Investment - Professor Peter Steinberg, CEO, BioSignal Ltd
|
|
Wed, 23 Apr 2008 03:30PM |
|
BOS - Collaboration to Develop Dental Devices - Mr Michael Oredsson, MD and CEO
|
|
Tue, 9 Jan 2007 02:00PM |
| Full Year Results | Fri, 29 Aug 2008 | |
| EGM | Thu, 29 May 2008 12:30PM |
|
| Interim Results | Thu, 28 Feb 2008 | |
| Annual General Meeting | Fri, 23 Nov 2007 10:00AM |
|
| Full Year Results | Mon, 27 Aug 2007 | |
| Interim Results | Wed, 28 Feb 2007 | |
| Annual General Meeting | Fri, 24 Nov 2006 10:00AM |
|
| Full Year Results | Wed, 30 Aug 2006 | |
| Interim Results | Mon, 13 Mar 2006 | |
| Annual General Meeting | Fri, 25 Nov 2005 10:00AM |
BIOSIGNAL LIMITED (BOS)
| Share Purchase Plan - Letter to Shareholders | Mon, 1 Sep 2008 |
| Preliminary Final Report | Fri, 29 Aug 2008 |
| Shareholder Update | Wed, 27 Aug 2008 |
| Ciba elects to cease industrial product evaluations | Wed, 6 Aug 2008 |
| Appendix 4C - quarterly | Fri, 25 Jul 2008 |
| ConocoPhillips to evaluate Biosignal corrosion treatment | Tue, 15 Jul 2008 |
| Collaboration with Animal Health Company | Fri, 4 Jul 2008 |
| Control of Industrial and Woundcare to Remain with Biosignal | Mon, 30 Jun 2008 |
| Lapse of Options | Tue, 10 Jun 2008 |
| Biosignal raises $400,000 in new equity | Tue, 3 Jun 2008 |
| Appendix 3B | Tue, 3 Jun 2008 |
| Change of Director`s Interest Notice x 3 | Tue, 3 Jun 2008 |
| First Collaboration on Agriculture Applications | Mon, 2 Jun 2008 |
| Results of Extraordinary General Meeting | Thu, 29 May 2008 |
| Notice of Extraordinary General Meeting | Tue, 29 Apr 2008 |
| Appendix 4C - quarterly | Mon, 28 Apr 2008 |
| CEO Presentation Excellence in Biotech Investment Conference | Tue, 22 Apr 2008 |
| Lapse of Unlisted Options | Tue, 1 Apr 2008 |
| Change of Director`s Interest Notice | Wed, 26 Mar 2008 |
| Partnership to commercialise industrial anti-bacterials | Tue, 11 Mar 2008 |
| Partners to commercialise wound and hospital antibacterials | Tue, 11 Mar 2008 |
| Appendix 3B | Fri, 7 Mar 2008 |
| Issue of Shares to Q-Stat | Fri, 7 Mar 2008 |
| Initial Director`s Interest Notice - Bruce Foy | Fri, 7 Mar 2008 |
| Biosignal appoints Bruce Foy non-executive director | Fri, 7 Mar 2008 |
| Issue of options to CEO Peter Steinberg | Tue, 4 Mar 2008 |
| Half Year Accounts | Thu, 28 Feb 2008 |
| Biosignal compounds in Dental Material cut Bacteria by 99% | Mon, 4 Feb 2008 |
| Investor Update | Tue, 18 Dec 2007 |
| Biosignal reduces oil and gas bacteria by 10,000 times | Wed, 28 Nov 2007 |
| Lapse of Unlisted Options | Tue, 27 Nov 2007 |
| Chairman`s Address to Shareholders | Fri, 23 Nov 2007 |
| CEO Presentation to Shareholders | Fri, 23 Nov 2007 |
| Results of AGM | Fri, 23 Nov 2007 |
| CIBA Study finds Biosignal compounds exceptional | Thu, 22 Nov 2007 |
| Section 708(5)(e) Notice | Thu, 15 Nov 2007 |
| Appendix 3B | Thu, 15 Nov 2007 |
| Lapse of Options | Mon, 12 Nov 2007 |
| Biosignal and Saraya to commercialise antibacterials | Fri, 9 Nov 2007 |
| Appendix 4C - quarterly | Fri, 26 Oct 2007 |
| Initiates Oil and Gas Field Trial on positive UK results | Thu, 25 Oct 2007 |
| Notice of Annual General Meeting | Fri, 19 Oct 2007 |
| Annual Report to shareholders | Fri, 28 Sep 2007 |
| Vesting of Options | Fri, 28 Sep 2007 |
| Shareholder Newsletter | Wed, 29 Aug 2007 |
| Preliminary Final Report | Mon, 27 Aug 2007 |
| Appendix 3B | Fri, 24 Aug 2007 |
| Final Director`s Interest Notice-Michael Oredsson | Mon, 13 Aug 2007 |
| Presentation by CEO Peter Steinberg | Mon, 6 Aug 2007 |
| Presentation by Director Gunter Pauli | Mon, 6 Aug 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.